I agree lots of good stuff there. But I have to s
Post# of 72447
Posted On: 07/07/2016 11:51:16 AM
I agree lots of good stuff there. But I have to say that I am not thrilled about the short term implications.
We all mostly knew from Leo's previous PR hints that a Phase 2b was likely on the table after the results of the phase 2 trial were released, so that was to be expected. The timing on it will be fast and that is a positive. The negative I interpret from it is that they are not close to closing a deal with BP on P like we have been hoping. The PR says they have: "fielded inquiries from many interested parties about the compound and has evaluated several options for the next stage of development." Dr. B goes on to say "I believe that Prurisol has that potential and that a refined second successful Phase 2 trial would further anchor the value that we already appreciate." Also you stated Dr. B is "making sure the clinical trials will be run in a way that will make Big Pharma understand what we've got."
Unfortunately that adds up in my mind to potential partners still undervaluing the drug and not putting acceptable numbers on the table yet. Therefore; we continue to push more trials to increase the value.
Now don't get me wrong, this is ultimately in our best longer term financial interests and I am not going to change my mind on my investment. If CTIX is not getting a fair value deal, then they either accept a lowball offer or spend the time and money to prove out the science and further justify the money that it is worth. But with this news I think that our potential for major short term price increase is pushing further out.
Hopefully we will all be presently surprised with significant news on the B front while we are all focusing on the P front.
Still long and strong CTIX!!!!
We all mostly knew from Leo's previous PR hints that a Phase 2b was likely on the table after the results of the phase 2 trial were released, so that was to be expected. The timing on it will be fast and that is a positive. The negative I interpret from it is that they are not close to closing a deal with BP on P like we have been hoping. The PR says they have: "fielded inquiries from many interested parties about the compound and has evaluated several options for the next stage of development." Dr. B goes on to say "I believe that Prurisol has that potential and that a refined second successful Phase 2 trial would further anchor the value that we already appreciate." Also you stated Dr. B is "making sure the clinical trials will be run in a way that will make Big Pharma understand what we've got."
Unfortunately that adds up in my mind to potential partners still undervaluing the drug and not putting acceptable numbers on the table yet. Therefore; we continue to push more trials to increase the value.
Now don't get me wrong, this is ultimately in our best longer term financial interests and I am not going to change my mind on my investment. If CTIX is not getting a fair value deal, then they either accept a lowball offer or spend the time and money to prove out the science and further justify the money that it is worth. But with this news I think that our potential for major short term price increase is pushing further out.
Hopefully we will all be presently surprised with significant news on the B front while we are all focusing on the P front.
Still long and strong CTIX!!!!
(2)
(0)